Glenview Capital Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.28M Buy
+18,018
New +$3.74M 0.08% 44
2024
Q1
Sell
-203,254
Closed -$20.5M 46
2023
Q4
$20.5M Sell
203,254
-54,076
-21% -$5.37M 0.44% 31
2023
Q3
$22.3M Hold
257,330
0.51% 32
2023
Q2
$24.3M Buy
257,330
+116,298
+82% +$9.82M 0.55% 27
2023
Q1
$10.6M Buy
+141,032
New +$10.6M 0.23% 44
2018
Q2
Sell
-3,016,195
Closed -$189M 51
2018
Q1
$189M Buy
3,016,195
+2,265,177
+302% +$155M 1.11% 33
2017
Q4
$46M Buy
+751,018
New +$46.4M 0.25% 52

Other funds holding CAH

Glenview Capital Management's CAH Position: Q2 2026 in Review

Glenview Capital Management opened a new position in Cardinal Health (CAH) in Q2 2026: 18,018 shares worth $4.28M. The stake represents 0.08% of the portfolio and ranks #44 among its holdings. This is a return to the name: Glenview Capital Management previously reported a position in CAH as recently as Q4 2023.

Glenview Capital Management first reported a position in CAH in Q4 2017 and has held it in 7 quarters since. The position peaked at $189M in Q1 2018. 1,498 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Glenview Capital Management held 18,018 shares of Cardinal Health worth $4.28M as of Q2 2026.
  • Cardinal Health was a new Glenview Capital Management position in Q2 2026.
  • Cardinal Health made up 0.08% of Glenview Capital Management's portfolio in Q2 2026, its #44 holding.
  • Glenview Capital Management first reported a position in Cardinal Health in Q4 2017 and has held it in 7 quarters since.
  • Glenview Capital Management's Cardinal Health position peaked at $189M in Q1 2018.
  • 1,498 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Glenview Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.